Stock Screener

Stock Screener · Library

Pacific Biosciences of California, Inc. financial statement history

Source-linked financial facts for Pacific Biosciences of California, Inc. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.

What this record covers

This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.

Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.

Total assets

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-312006970000USD2023-02-282022 / FYus-gaap:Assets10-K · 0001299130-23-000032
As of 2022-12-311767086000USD2024-02-282023 / FYus-gaap:Assets10-K · 0001299130-24-000054
As of 2023-12-311746013000USD2025-03-172024 / FYus-gaap:Assets10-K · 0001299130-25-000061
As of 2024-12-311260447000USD2026-02-252025 / FYus-gaap:Assets10-K · 0001299130-26-000034
As of 2025-12-31784083000USD2026-02-252025 / FYus-gaap:Assets10-K · 0001299130-26-000034

Current assets

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-311101134000USD2023-02-282022 / FYus-gaap:AssetsCurrent10-K · 0001299130-23-000032
As of 2022-12-31852074000USD2024-02-282023 / FYus-gaap:AssetsCurrent10-K · 0001299130-24-000054
As of 2023-12-31742047000USD2025-03-172024 / FYus-gaap:AssetsCurrent10-K · 0001299130-25-000061
As of 2024-12-31495681000USD2026-02-252025 / FYus-gaap:AssetsCurrent10-K · 0001299130-26-000034
As of 2025-12-31375052000USD2026-02-252025 / FYus-gaap:AssetsCurrent10-K · 0001299130-26-000034

Cash and cash equivalents

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-31460725000USD2024-02-282023 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001299130-24-000054
As of 2022-12-31325089000USD2025-03-172024 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001299130-25-000061
As of 2023-12-31179911000USD2026-02-252025 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001299130-26-000034
As of 2024-12-3155370000USD2026-02-252025 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001299130-26-000034
As of 2025-12-3163707000USD2026-02-252025 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001299130-26-000034

Inventory

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-3124599000USD2023-02-282022 / FYus-gaap:InventoryNet10-K · 0001299130-23-000032
As of 2022-12-3150381000USD2024-02-282023 / FYus-gaap:InventoryNet10-K · 0001299130-24-000054
As of 2023-12-3156676000USD2025-03-172024 / FYus-gaap:InventoryNet10-K · 0001299130-25-000061
As of 2024-12-3158755000USD2026-02-252025 / FYus-gaap:InventoryNet10-K · 0001299130-26-000034
As of 2025-12-3149285000USD2026-02-252025 / FYus-gaap:InventoryNet10-K · 0001299130-26-000034

Property, plant and equipment

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-3132504000USD2023-02-282022 / FYus-gaap:PropertyPlantAndEquipmentNet10-K · 0001299130-23-000032
As of 2022-12-3141580000USD2024-02-282023 / FYus-gaap:PropertyPlantAndEquipmentNet10-K · 0001299130-24-000054
As of 2023-12-3136432000USD2025-03-172024 / FYus-gaap:PropertyPlantAndEquipmentNet10-K · 0001299130-25-000061
As of 2024-12-3130505000USD2026-02-252025 / FYus-gaap:PropertyPlantAndEquipmentNet10-K · 0001299130-26-000034
As of 2025-12-3124146000USD2026-02-252025 / FYus-gaap:PropertyPlantAndEquipmentNet10-K · 0001299130-26-000034

Total liabilities

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-311215983000USD2023-02-282022 / FYus-gaap:Liabilities10-K · 0001299130-23-000032
As of 2022-12-311204182000USD2024-02-282023 / FYus-gaap:Liabilities10-K · 0001299130-24-000054
As of 2023-12-311044709000USD2025-03-172024 / FYus-gaap:Liabilities10-K · 0001299130-25-000061
As of 2024-12-31753853000USD2026-02-252025 / FYus-gaap:Liabilities10-K · 0001299130-26-000034
As of 2025-12-31778734000USD2026-02-252025 / FYus-gaap:Liabilities10-K · 0001299130-26-000034

Current liabilities

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-3171709000USD2023-02-282022 / FYus-gaap:LiabilitiesCurrent10-K · 0001299130-23-000032
As of 2022-12-31263335000USD2024-02-282023 / FYus-gaap:LiabilitiesCurrent10-K · 0001299130-24-000054
As of 2023-12-3195029000USD2025-03-172024 / FYus-gaap:LiabilitiesCurrent10-K · 0001299130-25-000061
As of 2024-12-3166299000USD2026-02-252025 / FYus-gaap:LiabilitiesCurrent10-K · 0001299130-26-000034
As of 2025-12-3172831000USD2026-02-252025 / FYus-gaap:LiabilitiesCurrent10-K · 0001299130-26-000034

Long-term debt

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-31896067000USD2022-02-282021 / FYus-gaap:LongTermDebt10-K · 0001299130-22-000030
As of 2022-12-31896683000USD2023-02-282022 / FYus-gaap:LongTermDebt10-K · 0001299130-23-000032

Stockholders equity

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-31790987000USD2025-03-172024 / FYus-gaap:StockholdersEquity10-K · 0001299130-25-000061
As of 2022-12-31562904000USD2026-02-252025 / FYus-gaap:StockholdersEquity10-K · 0001299130-26-000034
As of 2023-12-31701304000USD2026-02-252025 / FYus-gaap:StockholdersEquity10-K · 0001299130-26-000034
As of 2024-12-31506594000USD2026-02-252025 / FYus-gaap:StockholdersEquity10-K · 0001299130-26-000034
As of 2025-12-315349000USD2026-02-252025 / FYus-gaap:StockholdersEquity10-K · 0001299130-26-000034

Cost of revenue

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-3171653000USD2024-02-282023 / FYus-gaap:CostOfRevenue10-K · 0001299130-24-000054
2022-01-01 to 2022-12-3179269000USD2025-03-172024 / FYus-gaap:CostOfRevenue10-K · 0001299130-25-000061
2023-01-01 to 2023-12-31147741000USD2026-02-252025 / FYus-gaap:CostOfRevenue10-K · 0001299130-26-000034
2024-01-01 to 2024-12-31116732000USD2026-02-252025 / FYus-gaap:CostOfRevenue10-K · 0001299130-26-000034
2025-01-01 to 2025-12-31114225000USD2026-02-252025 / FYus-gaap:CostOfRevenue10-K · 0001299130-26-000034

Gross profit

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-3158860000USD2024-02-282023 / FYus-gaap:GrossProfit10-K · 0001299130-24-000054
2022-01-01 to 2022-12-3149035000USD2025-03-172024 / FYus-gaap:GrossProfit10-K · 0001299130-25-000061
2023-01-01 to 2023-12-3152780000USD2026-02-252025 / FYus-gaap:GrossProfit10-K · 0001299130-26-000034
2024-01-01 to 2024-12-3137282000USD2026-02-252025 / FYus-gaap:GrossProfit10-K · 0001299130-26-000034
2025-01-01 to 2025-12-3145780000USD2026-02-252025 / FYus-gaap:GrossProfit10-K · 0001299130-26-000034

Research and development

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-31112899000USD2024-02-282023 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001299130-24-000054
2022-01-01 to 2022-12-31193000000USD2025-03-172024 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001299130-25-000061
2023-01-01 to 2023-12-31187170000USD2026-02-252025 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001299130-26-000034
2024-01-01 to 2024-12-31134922000USD2026-02-252025 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001299130-26-000034
2025-01-01 to 2025-12-3197307000USD2026-02-252025 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001299130-26-000034

Operating income

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-31-210435000USD2024-02-282023 / FYus-gaap:OperatingIncomeLoss10-K · 0001299130-24-000054
2022-01-01 to 2022-12-31-307196000USD2025-03-172024 / FYus-gaap:OperatingIncomeLoss10-K · 0001299130-25-000061
2023-01-01 to 2023-12-31-334467000USD2026-02-252025 / FYus-gaap:OperatingIncomeLoss10-K · 0001299130-26-000034
2024-01-01 to 2024-12-31-474313000USD2026-02-252025 / FYus-gaap:OperatingIncomeLoss10-K · 0001299130-26-000034
2025-01-01 to 2025-12-31-553861000USD2026-02-252025 / FYus-gaap:OperatingIncomeLoss10-K · 0001299130-26-000034

Net income

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-31-181223000USD2024-02-282023 / FYus-gaap:NetIncomeLoss10-K · 0001299130-24-000054
2022-01-01 to 2022-12-31-314248000USD2025-03-172024 / FYus-gaap:NetIncomeLoss10-K · 0001299130-25-000061
2023-01-01 to 2023-12-31-306735000USD2026-02-252025 / FYus-gaap:NetIncomeLoss10-K · 0001299130-26-000034
2024-01-01 to 2024-12-31-309851000USD2026-02-252025 / FYus-gaap:NetIncomeLoss10-K · 0001299130-26-000034
2025-01-01 to 2025-12-31-546376000USD2026-02-252025 / FYus-gaap:NetIncomeLoss10-K · 0001299130-26-000034

Diluted earnings per share

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-31-0.89USD/shares2024-02-282023 / FYus-gaap:EarningsPerShareDiluted10-K · 0001299130-24-000054
2022-01-01 to 2022-12-31-1.4USD/shares2025-03-172024 / FYus-gaap:EarningsPerShareDiluted10-K · 0001299130-25-000061
2023-01-01 to 2023-12-31-1.21USD/shares2026-02-252025 / FYus-gaap:EarningsPerShareDiluted10-K · 0001299130-26-000034
2024-01-01 to 2024-12-31-1.59USD/shares2026-02-252025 / FYus-gaap:EarningsPerShareDiluted10-K · 0001299130-26-000034
2025-01-01 to 2025-12-31-1.82USD/shares2026-02-252025 / FYus-gaap:EarningsPerShareDiluted10-K · 0001299130-26-000034

Operating cash flow

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-31-111180000USD2024-02-282023 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001299130-24-000054
2022-01-01 to 2022-12-31-263211000USD2025-03-172024 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001299130-25-000061
2023-01-01 to 2023-12-31-259173000USD2026-02-252025 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001299130-26-000034
2024-01-01 to 2024-12-31-206058000USD2026-02-252025 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001299130-26-000034
2025-01-01 to 2025-12-31-111209000USD2026-02-252025 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001299130-26-000034

Capital expenditure

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-315931000USD2024-02-282023 / FYus-gaap:PaymentsToAcquirePropertyPlantAndEquipment10-K · 0001299130-24-000054
2022-01-01 to 2022-12-3116750000USD2025-03-172024 / FYus-gaap:PaymentsToAcquirePropertyPlantAndEquipment10-K · 0001299130-25-000061
2023-01-01 to 2023-12-318843000USD2026-02-252025 / FYus-gaap:PaymentsToAcquirePropertyPlantAndEquipment10-K · 0001299130-26-000034
2024-01-01 to 2024-12-316188000USD2026-02-252025 / FYus-gaap:PaymentsToAcquirePropertyPlantAndEquipment10-K · 0001299130-26-000034
2025-01-01 to 2025-12-312714000USD2026-02-252025 / FYus-gaap:PaymentsToAcquirePropertyPlantAndEquipment10-K · 0001299130-26-000034

Source and method

SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.

The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.

Source filer CIK
1299130
Ticker in native snapshot
PACB
Reported numeric facts
82
Units present
USD · USD/shares